Navigation Links
Common food additive found to increase risk and speed spread of lung cancer
Date:12/28/2008

New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease.

The study also suggests that dietary regulation of inorganic phosphates may play an important role in lung cancer treatment. The research, using a mouse model, was conducted by Myung-Haing Cho, D.V.M., Ph.D., and his colleagues at Seoul National University, appears in the first issue for January of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

"Our study indicates that increased intake of inorganic phosphates strongly stimulates lung cancer development in mice, and suggests that dietary regulation of inorganic phosphates may be critical for lung cancer treatment as well as prevention," said Dr. Cho.

Lung cancer is the number one cause of cancer deaths in the world and is also the most frequently diagnosed solid tumor. Nonsmall cell lung cancer (NSCLC) constitutes over 75 percent of lung cancers and has an average overall 35-year survival rate of 14 percent. Earlier studies have indicated that approximately 90 percent of NSCLC cases were associated with activation of certain signaling pathways in lung tissue. This study revealed that high levels of inorganic phosphates can stimulate those same pathways.

"Lung cancer is a disease of uncontrolled cell proliferation in lung tissue, and disruption of signaling pathways in those tissues can confer a normal cell with malignant properties," Dr. Cho explained. "Deregulation of only a small set of pathways can confer a normal cell with malignant properties, and these pathways are regulated in response to nutrient availability and, consequently, cell proliferation and growth.

"Phosphate i
'/>"/>

Contact: Keey Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Hairspray is linked to common genital birth defect, says study
2. GUMC researchers hone in on new strategy to treat common infection
3. First comprehensive genomic study of common cold reveals new treatment targets
4. Researchers identify Achilles heel of common childhood tumor
5. Study provides insight on a common heart rhythm disorder
6. U of M researchers identify gene linked to common ailment in labrador retrievers
7. The Clorox Companys new indoor allergen product reduces common indoor allergens up to 90 percent
8. Common treatment to delay labor decreases preterm infants risk for cerebral palsy
9. Why a common treatment for prostate cancer ultimately fails
10. Toxic chemicals found in common scented laundry products, air fresheners
11. Researchers identify cancer preventive properties in common vitamin supplement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... children with cancer, the hopeful news is that pe...decades. Among the bad newstreatments that enable ...osed with cancer who have reached puberty currentl... before undergoing cancer treatment, they may have...Younger boys, however, do not produce sperm, altho...
(Date:11/9/2009)...Ala. The U.S. Department of Energy (DOE) has anno...Alabama at Birmingham (UAB) School of Engineering ...gas emissions through the capture and permanent sa...O2). The project is in collaboration with Southern... Funded by the DOE through the 2009 American Recov...
(Date:11/9/2009)...ournal Naturwissenschaften is publishing a speci...dern Biology" to commemorate Darwin,s On the Origi...November 1859. Guest editor and author of the lead...nt physiology and evolutionary biology at the Univ...special issue are available free of charge until 3...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 1Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 2Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 1New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 2New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 4New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 5New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 6New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 7New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 8New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 9New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 10New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 11New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 12New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 13New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 14New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 15New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 16New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 17New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 18New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 19New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 20New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 21New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 22Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2
...ts including researchers at Cold Spring Harbor Lab...irst biomarker that permits neural stem and progen...n the brains of living human subjects. This import...gnosis and monitoring of brain tumors and a range ... , The biomarker is a lipid molecule whose presen...
...e National Institute of Standards of Technology (N... what is probably the worlds smallest microwave ov... drop of liquid inside a container slightly shorte...he micro microwave is intended for lab-on-a-chip d...es on tiny samples. , In a paper in the November ...
...ajor component of green tea could prove the perfec...tem response to a bacterial infection. In a new la...n Institute for Medical Research, and his colleagu...zens of Chinese herbal compounds in reversing a fa...very year. They found that an ingredient in green ...
Other Biology News:Team of scientists develops non-invasive method to track nerve-cell development in live human brain 2Micro microwave does pinpoint cooking for miniaturized labs 2In the laboratory, green tea proves a powerful medicine against severe sepsis 2
(Date:11/8/2009)...lif. Nov. 5, 2009 Complete Genomics, a third-gen...ounced publication of a report in the journal Sci...atform, including analysis of sequence data from t...for these three genomes sequenced on the proof-of-...5 for 87x coverage to $1,726 for 45x coverage for ...
(Date:11/6/2009)... 6 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/6/2009)... November 6 EUCODIS Bioscience, a ...d marketing enzymes for the,chemical industry anno...reement with Bio Sidus, the leading biopharmaceuti...ment gives EUCODIS Bioscience exclusive access - f...s, proprietary collection of,psychrophilic bacteri...
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...rmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceu...nd commercializing proprietary product candidates ...nced today that the company,s,President and CEO Th...ew on,Monday, June 23, 2008 at 1:05pm Eastern Time...ain Roundtable Conference at the Sofitel Hotel in ...
...nies, The Integra Group of Brooklyn Park and, Na...speed the path to market for advances ...and SAN DIEGO, June 17 Coinciding,with the BIO In...terventions introduces the "Mouse Stent Model" for...s. The model, complete with a mini-stent of,specta...
...,s focus in key areas in contract research, includ...l monitoring, and data management/e...7 PROMETRIKA, LLC, a contract,research organizati...vices,for clients in pharmaceuticals, biologics an...es Kolb has joined the company as senior director,...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York 2NanoInterventions Launches New, Rapid Testing System for Coronary Stents 2NanoInterventions Launches New, Rapid Testing System for Coronary Stents 3Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 3
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)
Canine IL-10 ELISpot Development Kit from R&D Systems
Equine TNF ALPHA from AbD Serotec
DETACHaBEAD CD19 from Dynal Biotech
Biology Products: